OptimizeRx Corporation (OPRX)
USD 4.78
(-8.6%)
USD 4.78
(-8.6%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 183.37 Million USD | 36.18% |
| 2022 | 134.65 Million USD | -4.49% |
| 2021 | 140.98 Million USD | 133.7% |
| 2020 | 60.32 Million USD | 6.51% |
| 2019 | 56.63 Million USD | 126.06% |
| 2018 | 25.05 Million USD | 156.61% |
| 2017 | 9.76 Million USD | -14.94% |
| 2016 | 11.47 Million USD | -6.78% |
| 2015 | 12.31 Million USD | 75.2% |
| 2014 | 7.02 Million USD | 75.37% |
| 2013 | 4 Million USD | 84.24% |
| 2012 | 2.17 Million USD | -24.79% |
| 2011 | 2.89 Million USD | -22.84% |
| 2010 | 3.74 Million USD | 321.13% |
| 2009 | 890.14 Thousand USD | -66.32% |
| 2008 | 2.64 Million USD | 796.14% |
| 2007 | 294.96 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 172.87 Million USD | -1.98% |
| 2024 Q1 | 176.36 Million USD | -3.82% |
| 2023 Q2 | 121.32 Million USD | -7.87% |
| 2023 Q3 | 123.92 Million USD | 2.15% |
| 2023 Q4 | 183.37 Million USD | 47.97% |
| 2023 Q1 | 131.69 Million USD | -2.2% |
| 2023 FY | 183.37 Million USD | 36.18% |
| 2022 Q3 | 135.87 Million USD | -7.85% |
| 2022 Q1 | 138.13 Million USD | -2.02% |
| 2022 Q2 | 147.44 Million USD | 6.74% |
| 2022 Q4 | 134.65 Million USD | -0.9% |
| 2022 FY | 134.65 Million USD | -4.49% |
| 2021 Q1 | 127.57 Million USD | 111.46% |
| 2021 Q3 | 134.65 Million USD | 2.3% |
| 2021 Q4 | 140.98 Million USD | 4.7% |
| 2021 FY | 140.98 Million USD | 133.7% |
| 2021 Q2 | 131.62 Million USD | 3.18% |
| 2020 Q1 | 56.23 Million USD | -0.71% |
| 2020 Q2 | 56.05 Million USD | -0.32% |
| 2020 FY | 60.32 Million USD | 6.51% |
| 2020 Q3 | 55.14 Million USD | -1.63% |
| 2020 Q4 | 60.32 Million USD | 9.4% |
| 2019 Q4 | 56.63 Million USD | 16.65% |
| 2019 FY | 56.63 Million USD | 126.06% |
| 2019 Q1 | 25.25 Million USD | 0.81% |
| 2019 Q2 | 49.63 Million USD | 96.53% |
| 2019 Q3 | 48.55 Million USD | -2.18% |
| 2018 Q4 | 25.05 Million USD | 26.79% |
| 2018 FY | 25.05 Million USD | 156.61% |
| 2018 Q1 | 9.27 Million USD | -5.03% |
| 2018 Q3 | 19.76 Million USD | 5.98% |
| 2018 Q2 | 18.64 Million USD | 101.08% |
| 2017 Q1 | 10.92 Million USD | -4.82% |
| 2017 Q2 | 10.47 Million USD | -4.09% |
| 2017 Q3 | 9.81 Million USD | -6.33% |
| 2017 Q4 | 9.76 Million USD | -0.52% |
| 2017 FY | 9.76 Million USD | -14.94% |
| 2016 Q2 | 10.99 Million USD | -0.91% |
| 2016 Q1 | 11.09 Million USD | -9.88% |
| 2016 Q3 | 11.26 Million USD | 2.41% |
| 2016 FY | 11.47 Million USD | -6.78% |
| 2016 Q4 | 11.47 Million USD | 1.93% |
| 2015 FY | 12.31 Million USD | 75.2% |
| 2015 Q1 | 6.75 Million USD | -3.84% |
| 2015 Q2 | 6.98 Million USD | 3.3% |
| 2015 Q3 | 12.31 Million USD | 76.45% |
| 2015 Q4 | 12.31 Million USD | -0.04% |
| 2014 Q1 | 6.51 Million USD | 62.56% |
| 2014 FY | 7.02 Million USD | 75.37% |
| 2014 Q4 | 7.02 Million USD | 10.25% |
| 2014 Q3 | 6.37 Million USD | 1.76% |
| 2014 Q2 | 6.26 Million USD | -3.83% |
| 2013 FY | 4 Million USD | 84.24% |
| 2013 Q1 | 2.14 Million USD | -1.54% |
| 2013 Q2 | 2.49 Million USD | 16.53% |
| 2013 Q3 | 2.82 Million USD | 13.15% |
| 2013 Q4 | 4 Million USD | 41.92% |
| 2012 Q2 | 2.41 Million USD | 2.43% |
| 2012 FY | 2.17 Million USD | -24.79% |
| 2012 Q4 | 2.17 Million USD | -2.2% |
| 2012 Q1 | 2.35 Million USD | -18.48% |
| 2012 Q3 | 2.22 Million USD | -7.9% |
| 2011 FY | 2.89 Million USD | -22.84% |
| 2011 Q1 | 3.55 Million USD | -5.21% |
| 2011 Q2 | 3.16 Million USD | -11.02% |
| 2011 Q3 | 2.64 Million USD | -16.2% |
| 2011 Q4 | 2.89 Million USD | 9.17% |
| 2010 Q2 | 2.45 Million USD | 287.23% |
| 2010 FY | 3.74 Million USD | 321.13% |
| 2010 Q4 | 3.74 Million USD | 82.6% |
| 2010 Q3 | 2.05 Million USD | -16.27% |
| 2010 Q1 | 633.18 Thousand USD | -28.87% |
| 2009 Q2 | 1.46 Million USD | -24.92% |
| 2009 Q1 | 1.95 Million USD | -26.08% |
| 2009 FY | 890.14 Thousand USD | -66.32% |
| 2009 Q4 | 890.14 Thousand USD | -21.48% |
| 2009 Q3 | 1.13 Million USD | -22.72% |
| 2008 FY | 2.64 Million USD | 796.14% |
| 2008 Q4 | 2.64 Million USD | 0.0% |
| 2007 FY | 294.96 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 1.97 Billion USD | 90.698% |
| GE HealthCare Technologies Inc. | 32.45 Billion USD | 99.435% |
| Sharecare, Inc. | 613.63 Million USD | 70.117% |
| Progyny, Inc. | 756.62 Million USD | 75.764% |
| Aclarion, Inc. | 2.45 Million USD | -7354.908% |
| CareMax, Inc. | 623.3 Million USD | 70.58% |
| Simulations Plus, Inc. | 196.63 Million USD | 6.746% |
| CareCloud, Inc. | 79.51 Million USD | -130.618% |
| Forian Inc. | 59.37 Million USD | -208.834% |
| Bullfrog AI Holdings, Inc. Warrants | 2.77 Million USD | -6504.294% |
| Bullfrog AI Holdings, Inc. Common Stock | 2.77 Million USD | -6504.294% |
| Minerva Surgical, Inc. | 68.9 Million USD | -166.145% |
| Omnicell, Inc. | 2.22 Billion USD | 91.765% |
| Definitive Healthcare Corp. | 1.82 Billion USD | 89.957% |
| Zhongchao Inc. | 24.41 Million USD | -651.02% |
| Accolade, Inc. | 788.15 Million USD | 76.734% |
| Streamline Health Solutions, Inc. | 41.74 Million USD | -339.324% |
| Ontrak, Inc. | 19.84 Million USD | -823.984% |
| SOPHiA GENETICS SA | 206.15 Million USD | 11.051% |
| R1 RCM Inc. | 4.96 Billion USD | 96.303% |
| Spok Holdings, Inc. | 227.68 Million USD | 19.461% |
| Privia Health Group, Inc. | 999.9 Million USD | 81.661% |
| EUDA Health Holdings Limited | 1.31 Million USD | -13892.581% |
| HeartBeam, Inc. | 17.13 Million USD | -970.421% |
| GeneDx Holdings Corp. | 473.67 Million USD | 61.287% |
| TruBridge, Inc. | 434.42 Million USD | 57.789% |
| Nutex Health, Inc. | 398.24 Million USD | 53.955% |
| Renalytix Plc | 7.97 Million USD | -2200.225% |
| Sharecare, Inc. | 613.63 Million USD | 70.117% |
| Health Catalyst, Inc. | 701.81 Million USD | 73.871% |
| 10x Genomics, Inc. | 965.14 Million USD | 81.0% |
| GoodRx Holdings, Inc. | 1.58 Billion USD | 88.458% |
| SCWorx Corp. | 6.27 Million USD | -2820.797% |
| Schrödinger, Inc. | 802.95 Million USD | 77.163% |
| HealthEquity, Inc. | 3.23 Billion USD | 94.334% |
| HealthStream, Inc. | 499.94 Million USD | 63.321% |
| MSP Recovery, Inc. | 3.15 Billion USD | 94.197% |
| Augmedix, Inc. | 66.71 Million USD | -174.874% |
| BrightSpring Health Services, Inc. Common Stock | 5.79 Billion USD | 96.833% |
| Ontrak, Inc. | 19.84 Million USD | -823.984% |
| SHL Telemedicine Ltd. | 113.04 Million USD | -62.206% |
| CareCloud, Inc. | 79.51 Million USD | -130.618% |
| Premier, Inc. | 3.42 Billion USD | 94.652% |
| Certara, Inc. | 1.56 Billion USD | 88.269% |
| GeneDx Holdings Corp. | 473.67 Million USD | 61.287% |
| OneMedNet Corporation | 463.05 Thousand USD | -39500.718% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.79 Billion USD | 96.833% |
| EUDA Health Holdings Limited | 1.31 Million USD | -13892.581% |
| HeartBeam, Inc. | 17.13 Million USD | -970.421% |
| CareCloud, Inc. | 79.51 Million USD | -130.618% |
| Mangoceuticals, Inc. | 1.05 Million USD | -17351.001% |
| CareMax, Inc. | 623.3 Million USD | 70.58% |
| Healthcare Triangle, Inc. | 10.04 Million USD | -1724.797% |
| National Research Corporation | 122.43 Million USD | -49.77% |
| Aclarion, Inc. | 2.45 Million USD | -7354.908% |